Editorial Optimizing management of patients with coronary artery disease: how do we get there?

This editorial refers to ‘Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization’† by M.J. Lenzen et al., on page 1169 Cardiovascular disease remains the leading cause of morbidity and mortality globally.1 Despite marked advances in the fields of mechanical and pharmacological therapies for coronary artery disease there continues to remain large gaps in the utilization of these effective therapies. Over the last decade, several pharmacological therapies have been shown to be very effective in reducing morbidity and mortality in patients with cardio-vascular diseases. These agents, including antiplatelet agents, statins, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers